SCHEMBL12705158

SCHEMBL12705158

O=C(OC1CCCCOC1=O)C(F)F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.40
ALDH1A1 P00352 5/20 0.37
KDM4E B2RXH2 3/20 0.37
HPGD P15428 3/20 0.37
HSD17B10 Q99714 2/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
MAPK1 P28482 4/20 0.35
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
TSHR P16473 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
NPC1 O15118 1/20 0.32
HCRTR1 O43613 1/20 0.32
USP2 O75604 1/20 0.32
TP53 P04637 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12256177 0.95 POLB (0.40) POLBALDH1A1KDM4EHPGDHSD17B10
SCHEMBL12256175 0.88 POLB (0.49) POLBALDH1A1KDM4EHPGDHSD17B10
SCHEMBL12705400 0.81 MAPK1 (0.38) POLBALDH1A1KDM4EHPGDHSD17B10
SCHEMBL21396856 0.79 ALDH1A1 (0.37) POLBALDH1A1KDM4EHPGDHSD17B10
SCHEMBL12705164 0.75 POLB (0.54) POLBALDH1A1KDM4EHPGDHSD17B10
SCHEMBL685838 0.75 POLB (0.38) POLBALDH1A1KDM4EHPGDHSD17B10
SCHEMBL12705206 0.75 ALDH1A1 (0.44) POLBALDH1A1KDM4EHSD17B10SMN1; SMN2
SCHEMBL30525802 0.74 POLB (0.37) POLBALDH1A1KDM4EHPGDHSD17B10
SCHEMBL18748723 0.74 KDM4E (0.43) POLBALDH1A1KDM4EHPGDHSD17B10
SCHEMBL12705372 0.74 MAPK1 (0.45) POLBALDH1A1KDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110091808-A1 PHOTORESIST COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110091808-A1 PHOTORESIST COMPOSITION ASIC1, ASIC3, SUN2 POLB 847/4885ALDH1A1 2111/4885KDM4E 3478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.